Repligen Corp Sustainability Reports
Repligen Corporation develops and manufactures bioprocessing technologies, systems, and consumables used to improve biological drug production. Its product portfolio includes protein ligands, chromatography, and filtration systems sold to global life sciences and biopharmaceutical companies.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 54930006QJ0T5AUO1E71
FIGI: BBG001S5VNT9
16 reports from 2009 to 2025